Cell Line Quality Technologies

BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Oct 15, 2016
Volume 2016 eBook, Issue 2, pg s23-s25

Chinese hamster ovary (CHO) cells are a common and stable option for mammalian expression systems, but what are the other cell line options in upstream processing and how do they compare in quality and stability to CHO cells? And what are the best techniques for ensuring quality and stability in cell-line development?  BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances and the analytical techniques companies can use to ensure quality and stability.

Read this article from BioPharm International’s Bioprocessing Trends 2016 eBook.

View other articles in the Bioprocessing Trends 2016 eBook.

native1_300x100
lorem ipsum